Rotavirus Bulletin
Rotaviruses are estimated to be responsible for approximately 530 000 under 5 deaths each year globally. More importantly, it is a very important cause of hospitalization and child morbidity in developing countries. Children under 5 years of age, especially those between 6 months and 2 years, are most vulnerable. Two new vaccines against rotavirus infections got licensed in 2006, which are considered to be safe and efficacious. WHO has recommended use of these vaccines in national immunization programs in Europe and Americas. Data from the clinical trials in Africa and Asia is expected soon to facilitate recommendations for developing countries in Asia and Africa.

Rotavirus Vaccines - WHO Position Paper

Regional strategy for increasing access to and utilization of new and underutilized vaccines (2009 -2015)
Significant strides have been made towards implementing essential immunization practices in developing countries in the Region. However, complexities of new vaccines and the obstacles faced in bringing them to vulnerable populations demand continued action. The plan outlines the achievements in the Region with regard to new vaccines and presents objectives and future activities aimed at building upon those achievements.

Technical Advisory Group (TAG) on Immunization and Vaccine Preventable Diseases in the Western Pacific Region (18th Meeting - 30 June-2 July 2009) - Meeting Report
The 18th meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine-Preventable Diseases (VPDs) in the Western Pacific Region (WPR) was held from 30 June to 2 July 2009 in Manila, Philippines. A meeting of the Regional Interagency Coordinating Committee was convened concurrently with the TAG Meeting, as in previous years.

[more publications and documents]